Drug or treatment

Romosozumab clinical trials

• 8Clinical trials
• 7Countries

Newest trials

All recruiting trials (8)

• How the body absorbs romosozumab from one big shot vs two smaller injections

  This study tests whether a single large subcutaneous injection of romosozumab delivers the same amount of drug in the body as two smaller injections in healthy adults.

  Recruiting at 2 sites Phase 1 Amgen · Miami, Florida and 1 other locations · NCT07811999

• Romosozumab for bone formation in people with breast cancer and osteoporosis

  This study tests whether romosozumab can help build bone in adults with metastatic breast cancer that has spread to bone and who also have osteoporosis.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07776613

• MicroRNA and bone markers linked to response to romosozumab and abaloparatide in postmenopausal osteoporosis

  Researchers will test whether microRNA and other bone markers can predict how well postmenopausal women with osteoporosis respond to romosozumab and abaloparatide.

  Recruiting Istituto Auxologico Italiano · Miano, Lombardy and 1 other locations · NCT07616401

• Pediatric safety follow-up after romosozumab treatment for osteogenesis imperfecta

  This follow-up tests the safety of romosozumab in children and adolescents with osteogenesis imperfecta who previously received romosozumab in an earlier trial.

  Recruiting at 4 sites Phase 3 Amgen · Indianapolis, Indiana and 3 other locations · NCT07366086

• Romosozumab and denosumab alone or together for postmenopausal osteoporosis

  This 6-month pilot tests whether cyclic romosozumab combined with denosumab improves bone density more than denosumab alone in postmenopausal women with osteoporosis.

  Recruiting Phase 4 National Taiwan University Hospital · Douliu, Taiwan · NCT07283887

• Comparing two treatment regimens for osteoporosis in postmenopausal women

  This study is testing two different treatment plans for osteoporosis in postmenopausal women to see which one helps improve bone strength and reduce the risk of fractures better.

  Recruiting Phase 4 National Taiwan University Hospital · Taipei · NCT06938152

• Using romosozumab to improve bone density in women with functional hypothalamic amenorrhea

  This study is testing if a medication called romosozumab can help improve bone density in girls and women aged 14-25 who have low bone density due to functional hypothalamic amenorrhea.

  Recruiting at 2 sites Phase 3 Massachusetts General Hospital · Boston, Massachusetts and 1 other locations · NCT06533865

• Evaluating treatments after osteoanabolic therapy for osteoporosis

  This study is testing different follow-up treatments for Caucasian women with severe osteoporosis after they’ve finished a specific therapy to see which one helps improve their bone health the most.

  Recruiting at 8 sites 424 General Military Hospital · Athens and 7 other locations · NCT06164795

Quick answers

How many clinical trials of Romosozumab are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (4 trials), Taiwan (2 trials), Italy (2 trials), Greece (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 2, Phase 3: 2, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →